NASDAQ

Altimmune, Inc. (ALT)

♥ 569 Thanks from members

Live price chart, market sentiment, and community perspectives for Altimmune, Inc. (NASDAQ: ALT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Altimmune Research TeamLeadership: Vipin K. Garg (President and CEO)Leadership: Scot Harper (CSO)Holder: Baker Bros. AdvisorsHolder: The Vanguard GroupHolder: BlackRockPemvidutide (Obesity/MASH)Nasally Administered VaccinesImmunotherapy Treatments#ALT stock#Altimmune biopharma#pemvidutide#obesity drugs#biotech clinical trials